Compare BMHL & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMHL | EDAP |
|---|---|---|
| Founded | 2016 | 1979 |
| Country | Hong Kong | France |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.5M | 75.5M |
| IPO Year | 2025 | 1997 |
| Metric | BMHL | EDAP |
|---|---|---|
| Price | $3.65 | $3.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 4.4K | ★ 67.0K |
| Earning Date | 01-09-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.50 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | $6,873,097.00 | ★ $74,853,925.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.67 |
| P/E Ratio | $62.59 | ★ N/A |
| Revenue Growth | ★ 66.02 | 0.61 |
| 52 Week Low | $2.72 | $1.21 |
| 52 Week High | $4.49 | $3.45 |
| Indicator | BMHL | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 63.81 |
| Support Level | N/A | $2.70 |
| Resistance Level | N/A | $3.45 |
| Average True Range (ATR) | 0.00 | 0.34 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 0.00 | 85.16 |
Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.